Cambridge Investment Research Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,782
Closed -$209K 2310
2018
Q2
$209K Buy
+4,782
New +$225K ﹤0.01% 1989
2018
Q1
Sell
-11,466
Closed -$755K 2236
2017
Q4
$755K Sell
11,466
-2,304
-17% -$147K 0.01% 1058
2017
Q3
$824K Sell
13,770
-62
-0.4% -$3.69K 0.01% 939
2017
Q2
$897K Sell
13,832
-2
-0% -$126 0.01% 859
2017
Q1
$864K Buy
13,834
+590
+4% +$35.5K 0.01% 798
2016
Q4
$765K Buy
13,244
+2,018
+18% +$119K 0.01% 812
2016
Q3
$667K Buy
11,226
+2,141
+24% +$132K 0.01% 882
2016
Q2
$564K Sell
9,085
-49
-0.5% -$3.02K 0.01% 882
2016
Q1
$563K Buy
9,134
+437
+5% +$25.8K 0.01% 836
2015
Q4
$529K Sell
8,697
-443
-5% -$26.4K 0.01% 830
2015
Q3
$462K Buy
9,140
+653
+8% +$34.8K 0.01% 792
2015
Q2
$437K Buy
+8,487
New +$439K 0.01% 876

Other funds holding XRAY

Cambridge Investment Research Advisors's XRAY Position: Q3 2018 in Review

Cambridge Investment Research Advisors sold out of Dentsply Sirona (XRAY) in Q3 2018, closing a stake of 4,782 shares — an estimated $209K sold.

Cambridge Investment Research Advisors first reported a position in XRAY in Q2 2015 and held it in 12 quarters. The position peaked at $897K in Q2 2017. 521 funds tracked by Wall St. Rank hold XRAY as of Q3 2018.

  • Cambridge Investment Research Advisors reported no remaining Dentsply Sirona position as of Q3 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 4,782 Dentsply Sirona shares in Q3 2018, an estimated $209K.
  • Cambridge Investment Research Advisors first reported a position in Dentsply Sirona in Q2 2015 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's Dentsply Sirona position peaked at $897K in Q2 2017.
  • 521 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.